PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Incyte Research Institute, Incyte Corporation, 1801 Augustine Road, Wilmington, DE 19803, USA. Electronic address: Yeleswaram@incyte.com.\', \'Incyte Research Institute, Incyte Corporation, 1801 Augustine Road, Wilmington, DE 19803, USA. Electronic address: PSmith@incyte.com.\', \'Incyte Research Institute, Incyte Corporation, 1801 Augustine Road, Wilmington, DE 19803, USA. Electronic address: TBurn@incyte.com.\', \'Incyte Research Institute, Incyte Corporation, 1801 Augustine Road, Wilmington, DE 19803, USA. Electronic address: MCovington@incyte.com.\', \'Incyte Research Institute, Incyte Corporation, 1801 Augustine Road, Wilmington, DE 19803, USA. Electronic address: ajuvekar@incyte.com.\', \'Incyte Research Institute, Incyte Corporation, 1801 Augustine Road, Wilmington, DE 19803, USA. Electronic address: YLi@incyte.com.\', \'Incyte Corporation, 1801 Augustine Road, Wilmington, DE 19803, USA. Electronic address: MSquier@incyte.com.\', \'Incyte Corporation, 1801 Augustine Road, Wilmington, DE 19803, USA. Electronic address: plangmuir@incyte.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1521-6616(20)30397-110.1016/j.clim.2020.108517
?:hasPublicationType
?:journal
  • Clinical immunology (Orlando, Fla.)
is ?:pmid of
?:pmid
?:pmid
  • 32585295
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all